Fluor (FLR) insider files Form 144 to sell 15,313 shares

Fluor Corporation (FLR) reported a planned insider sale of common stock under Rule 144.

Rhea-AI Filing Summary

Fluor Corporation (FLR) reported a planned insider sale of common stock under Rule 144. The filing shows an intention to sell 15,313 common shares through Merrill Lynch, with an aggregate market value of $832,410, on or about 11/17/2025 on the NYSE. These shares come from multiple restricted stock equity awards granted between 2016 and 2023. Shares of Fluor common stock outstanding were 161,182,507 as of the date referenced, which serves as a baseline figure for the company’s capital structure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Fluor (FLR) disclose in this Form 144 filing?

The filing discloses a planned insider sale of 15,313 Fluor common shares under Rule 144, to be executed through Merrill Lynch on the NYSE.

How many Fluor (FLR) shares are planned to be sold and at what value?

The notice states an intention to sell 15,313 common shares with an aggregate market value of $832,410 as reported in the filing.

When is the planned sale date for the Fluor (FLR) shares under Form 144?

The approximate date of sale indicated is 11/17/2025, with the transaction expected to take place on the NYSE.

How were the Fluor (FLR) shares being sold under Form 144 originally acquired?

The shares were acquired as restricted stock from Fluor Corporation through multiple equity awards granted between 2016 and 2023.

How many Fluor (FLR) shares were outstanding at the time referenced in the filing?

The Form 144 lists 161,182,507 Fluor common shares outstanding, providing a baseline view of the company’s total common stock at that time.

Which broker and exchange will handle the planned Fluor (FLR) share sale?

The planned sale is to be executed through Merrill Lynch, with the shares to be sold on the New York Stock Exchange (NYSE).

What representation does the insider make in the Fluor (FLR) Form 144?

By signing, the insider represents that they do not know any material adverse information about Fluor’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/17/2025 - 03:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002011864
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FLUOR CORPORATION
SEC File Number	001-16129
Address of Issuer	6700 LAS COLINAS BLVD IRVING TEXAS 75039
Phone	4693987000
Name of Person for Whose Account the Securities are To Be Sold	ANTHONY MORGAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 13355 Noel Road Suite Suite 700 Dallas TX 75240	15313	832410	161182507	11/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	07/06/2017	RESTRICTED STOCK	FLUOR CORPORATION			3	07/06/2017	EQUITY AWARD
COMMON	10/04/2017	RESTRICTED STOCK	FLUOR CORPORATION			5	10/04/2017	EQUITY AWARD
COMMON	01/04/2018	RESTRICTED STOCK	FLUOR CORPORATION			3	01/04/2018	EQUITY AWARD
COMMON	04/04/2018	RESTRICTED STOCK	FLUOR CORPORATION			3	04/04/2018	EQUITY AWARD
COMMON	07/05/2018	RESTRICTED STOCK	FLUOR CORPORATION			8	07/05/2018	EQUITY AWARD
COMMON	10/03/2018	RESTRICTED STOCK	FLUOR CORPORATION			4	10/03/2018	EQUITY AWARD
COMMON	01/04/2019	RESTRICTED STOCK	FLUOR CORPORATION			7	01/04/2019	EQUITY AWARD
COMMON	03/06/2020	RESTRICTED STOCK	FLUOR CORPORATION			1531	03/06/2020	EQUITY AWARD
COMMON	03/06/2021	RESTRICTED STOCK	FLUOR CORPORATION			1956	03/06/2021	EQUITY AWARD
COMMON	03/06/2022	RESTRICTED STOCK	FLUOR CORPORATION			1797	03/06/2022	EQUITY AWARD
COMMON	03/06/2023	RESTRICTED STOCK	FLUOR CORPORATION			3183	03/06/2023	EQUITY AWARD
COMMON	02/23/2016	RESTRICTED STOCK	FLUOR CORPORATION			3387	02/23/2016	EQUITY AWARD
COMMON	02/23/2017	RESTRICTED STOCK	FLUOR CORPORATION			3426	02/23/2017	EQUITY AWARD

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/17/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	ANTHONY MORGAN
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)